Moreover, CCL2 enhances vascular permeability and pulmonary metastases71, while CXCL2 promotes chemoresistances and metastases in lung and breast cancers72, and is overexpressed in glioblastoma (GBM) to promote tumor progression73. The gene discussed is CCL2; the disease is neoplasm.